Clinical Trial Update: A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of Orforglipron (LY3502970) in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED